| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7d20a0283a9d0731796739ef4b06d6f4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a44f33e8a121513cba8b28a01230594
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d3a4136b7ef1d0ad22f0b5f320bfe9b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_194fd585df029cc7dc6ee9d40131db84 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-412
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-44 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-44 |
| filingDate |
2012-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eba7ab090c98eb4adf8cb41f96996b2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_464a86ebaf16e1cc1fe74c0aed5ce527
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_444a1fb16e9e2e0bb6daf4259ba95790 |
| publicationDate |
2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10604551-B2 |
| titleOfInvention |
Use of an L3 and/or L5 source as a vaccine or as a diagnostic for a parasitic disease |
| abstract |
The invention relates to composition comprising an L3 and/or an L5 source and optionally an adjuvant for the preparation of a medicine for the treatment or prevention of a parasitic disease and to its diagnostic use of said parasitic disease. |
| priorityDate |
2009-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |